Hyperreflective foci in predicting the treatment outcome of antivascular endothelial growth factor in neovascular age-related macular degeneration

被引:18
|
作者
Hsia, Yun [1 ]
Yang, Chang-Hao [1 ,2 ]
Hsieh, Yi-Ting [1 ]
Yang, Chung-May [1 ,2 ]
Ho, Tzyy-Chang [1 ]
Lai, Tso-Ting [1 ,3 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Ophthalmol, Taipei, Taiwan
[3] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
关键词
Antivascular endothelial growth factor; Hyperreflective foci; Neovascular age-related macular degeneration; Subretinal fluid; OPTICAL COHERENCE TOMOGRAPHY; OUTER RETINA; VISUAL OUTCOMES; PROGRESSION; BIOMARKERS; MICROGLIA;
D O I
10.1007/s00417-019-04546-1
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To describe the optical coherence tomographic findings of hyperreflective foci (HF) in neovascular age-related macular degeneration and evaluate the use of HF to predict visual outcome after antivascular endothelium growth factor (anti-VEGF) therapy. Methods This was a post-hoc analysis of a retrospective cohort study. Hyperreflective foci were localized in the inner retina, outer retina, or subretinal fluid (SRF) layer. The treatment response of HF was recorded. The association between HF and visual outcome was analyzed. Results We enrolled 126 eyes. Hyperreflective foci involving more than one layer were associated with poor initial visual acuity (P < 0.001). Hyperreflective foci in each layer at baseline were negatively correlated with baseline visual acuity. At 3 months posttreatment, HF in the SRF layer had decreased significantly (P = 0.003), which was faster compared with HF in other layers. Baseline HF status at each layer was not associated with final visual outcome. The eyes with reduced HF in the SRF at 3 months had better visual improvement at 12 months (P = 0.038). Conclusion Hyperreflective foci involving multiple layers were associated with poor initial visual acuity but not with final visual outcome. With anti-VEGF treatment, HF in the SRF layer resolved faster, which may predict better visual outcome.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [31] Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy
    Huang, Chu-Hsuan
    Yang, Chang-Hao
    Hsieh, Yi-Ting
    Yang, Chung-May
    Ho, Tzyy-Chang
    Lai, Tso-Ting
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Efficacy of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-Related Macular Degeneration and Systemic Cardiovascular Risk Factors
    Ladkowska, Joanna
    Gawecki, Maciej
    Szolkiewicz, Marek
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [33] Relationship Between Subretinal Hyperreflective Material Reflectivity and Volume in Patients With Neovascular Age-Related Macular Degeneration Following Anti-Vascular Endothelial Growth Factor Treatment
    Charafeddin, Wissam
    Nittala, Muneeswar Gupta
    Oregon, Aldo
    Sadda, SriniVas R.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (05) : 523 - 530
  • [34] Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
    Hata, Masayuki
    Yamashiro, Kenji
    Ooto, Sotaro
    Oishi, Akio
    Tamura, Hiroshi
    Miyata, Manabu
    Ueda-Arakawa, Naoko
    Takahashi, Ayako
    Tsujikawa, Akitaka
    Yoshimura, Nagahisa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (01) : 292 - 298
  • [35] Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration
    Pitlick, Jamie M.
    Vecera, Kayla F.
    Barnes, Kylie N.
    Reski, John W.
    Forinash, Alicia B.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (02) : 290 - 296
  • [36] Macular thickness fluctuation in neovascular age-related macular degeneration treated with anti- vascular endothelial growth factor
    Chen, Eric R.
    Chen, Andrew X.
    Greenlee, Tyler E.
    Conti, Thais F.
    Briskin, Isaac N.
    Urbano, Catherine A.
    Kalur, Aneesha
    Kaiser, Peter K.
    Singh, Rishi P.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2022, 57 (05): : 350 - 356
  • [37] Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration
    Baris, Mine Esen
    Mentes, Jale
    Afrashi, Filiz
    Nalcaci, Serhad
    Akkin, Cezmi
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2020, 50 (05): : 275 - 282
  • [38] The relationship between vascular endothelial dysfunction and treatment frequency in neovascular age-related macular degeneration
    Ueda-Consolvo, Tomoko
    Hayashi, Atsushi
    Ozaki, Mayumi
    Nakamura, Tomoko
    Yagou, Takaaki
    Abe, Shinya
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (04) : 347 - 353
  • [39] The relationship between vascular endothelial dysfunction and treatment frequency in neovascular age-related macular degeneration
    Tomoko Ueda-Consolvo
    Atsushi Hayashi
    Mayumi Ozaki
    Tomoko Nakamura
    Takaaki Yagou
    Shinya Abe
    Japanese Journal of Ophthalmology, 2017, 61 : 347 - 353
  • [40] GEOGRAPHIC ATROPHY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Xu, Luna
    Mrejen, Sarah
    Jung, Jesse J.
    Gallego-Pinazo, Roberto
    Thompson, Desmond
    Marsiglia, Marcela
    Freund, K. Bailey
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (02): : 176 - 186